Watch Ticker

Tyra Biosciences, Inc. Common Stock

Go to Tyra Biosciences, Inc. Common Stock Website

$11.50

0.85 (7.98%)

Live

Previous Close

$10.65

Day Range

$10.34 - $11.72

Previous Day Range

$10 - $10.74

Market Cap

$551.5 million USD

Day Vol.

194323

Previous Day Vol.

218424

Currency

USD

Primary Exchange

Nasdaq

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine pl...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight

BALVERSA (erdafitinib), a targeted therapy for FGFR-altered urothelial carcinoma, has strong market potential as precision oncology gains emphasis. Its uptake is expected to increase, especially if expanded to earlier treatment lines or additional FGFR-driven tumors.

Related tickers: JNJ, AZN, PFE, TYRA, URGN.

Read Full Article

Delveinsight - Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The advanced urothelial carcinoma market is witnessing significant growth, driven by an aging population and the rising prevalence of metastatic cases. Advances in immunotherapy and targeted treatments are transforming the treatment landscape, with over 20 key companies developing new therapies.

Related tickers: BCYC, BMY, CELGr, TYRA, BGNE, ONC.

Read Full Article

Trending Tickers

Please sign in to view